Challenges in treating malignancies in HIV in NigeriaPazopanib in sarcomas: expanding the PALETTEOral human papillomavirus infection and head and neck cancers in HIV-infected individualsCombining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapyContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerHIV infection, aging, and immune function: implications for cancer risk and preventionCancer stem cells: relevance to clinical transplantationTargeted therapeutic strategies for the management of renal cell carcinomaScreening guidelines for non-AIDS defining cancers in HIV-infected individualsGain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic interventionBiomarkers in prostate cancer: what's new?New and emerging developments in extensive-stage small cell lung cancer therapeuticsSmart CARs engineered for cancer immunotherapyChemobrain: is systemic chemotherapy neurotoxic?Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatmentMerkel cell carcinoma: recent insights and new treatment optionsPhosphatases and tumorigenesisApply innovative technologies to explore cancer genomeMelanoma vaccines.AIDS-associated cancer in developing nations.A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?Challenges and opportunities for treatment and research of AIDS-related malignancies in Africa.Enhancement of thymidylate synthase inhibition.Evaluation of cost of home therapy for patients with terminal diseases.Surgery for breast cancer.Biology and therapy of mantle cell lymphoma.Molecular advances in prostate cancer.Intraoperative imaging techniques in the treatment of brain tumors.Update on the role of ipilimumab in melanoma and first data on new combination therapies.Magnetic resonance spectroscopy of brain tumors.Nonoperative management of low-risk differentiated thyroid carcinoma.Familial thyroid cancer.New advances in brain tumor imaging.The potential of proton magnetic resonance spectroscopy ((1)H-MRS) in the diagnosis and management of patients with brain tumors.Aspirin in gastrointestinal oncology: new data on an old friend.Statistical methods applied to omics data: predicting response to neoadjuvant therapy in breast cancer.Perspectives for immunotherapy in glioblastoma treatment.Surveillance recommendations for patients with germline TP53 mutations.Revisiting robotic approaches to endocrine neoplasia: do the data support their continued use?Screening, staging, and diagnostic investigation of non-small cell lung cancer patients.
P1433
Q24628763-8324C778-30AA-4F2B-AC89-E396670A7F8FQ26825050-6E256C73-6FE1-44F9-B298-EAB30A0520ABQ26825257-4C86481C-BCC0-4517-9D2C-9F54EFBCFA90Q26851608-DD607B1A-312C-4C9A-91BE-4BEEBA6EE0ADQ26992106-B3328F7E-6A3A-471D-9AD1-BA96FFA9FAD2Q27004165-AB77464A-365C-4AF3-8131-7B8B9436320CQ27008959-0341D846-3EB0-41E8-9E9C-CE7F97C58B76Q27013846-5FCCC000-B0B3-4C8D-9E4E-32BC58EADA4AQ27021899-3C2A43E3-DBD0-4CFC-9E42-2301BD747BC4Q27024233-78C0D6BE-2262-4ACC-91B6-13C696C69C45Q27026210-9AD6B985-BFA4-4D1B-9584-F32C5358D912Q28076304-DC6E4CA1-2F25-469F-BB91-0F31A0AAA5F5Q28087236-0D46807B-3CC3-48A9-812C-5A9F3D4ACB22Q28251371-CBD8C80E-C3CE-4ADE-83FC-89EBCBD104B5Q28254438-4C1D2A05-4345-46F2-865C-2666FDC69B5CQ28257160-00439948-31F8-4BE0-A93D-3265ABE4B979Q28261948-A65AB30C-B0D3-45A9-9C4E-10870792DD97Q28299058-30DB6011-5625-4884-ABAF-4CEFF645EB70Q30305535-63FFDBDE-B4E4-4F2D-A96C-A14E08CDDB3EQ30342705-DE9144E7-2303-495C-9180-DB2F0550E03DQ30353473-0227F88B-9571-4C10-A52E-F8F68D3530E7Q30356096-250597C5-043F-44CB-BF44-D761252F5B3FQ30421822-A978194A-0FBB-41D7-B89E-75BFABCDB5CBQ30431241-DE02D91F-9F3B-40C3-B68F-C44F08400679Q30431981-013BB9CF-8E83-46C0-AFBE-B8DE065FB68BQ30437744-B5380D0E-1A04-4F08-8AEC-539426ED9D4FQ30470232-E5019B45-61A2-4D97-AE83-977357E5C6B6Q30577262-FCDACFA2-992F-4710-B84E-F6FEA91EFDC2Q30585096-D0ACF06D-ECC9-4B72-982B-5503EBB9EB10Q30597065-1C92BAE6-843D-47DB-9EB7-B3F1F4531F85Q30605108-A674A771-C1FF-4D21-8AD4-35A35455578AQ30624270-EEE582C7-4493-4967-8E46-2E728E0A62B2Q30648494-691704C7-7CE1-494E-B5D2-2898676F6670Q30690121-50DFF60E-1B55-40A0-9FF2-7C3E1D39C9C2Q30823929-6FE18D51-DF8F-4FF9-A7EF-B9F354246E04Q30850557-A7833293-0BE3-4270-B348-C6500CC257DCQ30850560-5C7A7147-108E-48C5-AC11-E7C01CD8C45FQ30967044-C2161841-A5BB-4C5D-BF41-2045AC052009Q31030023-4C3AD3C3-61BC-46BD-B699-DFA1097EF801Q31032702-90BBBB46-B7FC-407F-BBA5-723546C920DC
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Lippincott Williams & Wilkins
@nl
рецензований науковий журнал
@uk
name
Current Opinion in Oncology
@ast
Current Opinion in Oncology
@da
Current Opinion in Oncology
@de
Current Opinion in Oncology
@en
Current Opinion in Oncology
@es
Current Opinion in Oncology
@fi
Current Opinion in Oncology
@fr
Current Opinion in Oncology
@it
Current Opinion in Oncology
@nb
Current Opinion in Oncology
@nl
type
label
Current Opinion in Oncology
@ast
Current Opinion in Oncology
@da
Current Opinion in Oncology
@de
Current Opinion in Oncology
@en
Current Opinion in Oncology
@es
Current Opinion in Oncology
@fi
Current Opinion in Oncology
@fr
Current Opinion in Oncology
@it
Current Opinion in Oncology
@nb
Current Opinion in Oncology
@nl
prefLabel
Current Opinion in Oncology
@ast
Current Opinion in Oncology
@da
Current Opinion in Oncology
@de
Current Opinion in Oncology
@en
Current Opinion in Oncology
@es
Current Opinion in Oncology
@fi
Current Opinion in Oncology
@fr
Current Opinion in Oncology
@it
Current Opinion in Oncology
@nb
Current Opinion in Oncology
@nl
P3181
P1055
P1058
P1156
P1250
P1277
P1476
Current Opinion in Oncology
@en
P236
P571
1989-01-01T00:00:00Z